We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia.
- Authors
Amitabh, Vindu; Singhal, Anish; Kumar, Sudhir; Patel, Narmada; Rizvi, Yasir S; Mishra, Pankaj
- Abstract
Respiratory tract infections (RTI) are common causes of morbidity and mortality worldwide. Initial antibiotic therapy in upper and lower respiratory tract infections is usually empirical. The increasing evidence of antibacterial resistance in the pathogens commonly associated with pneumonia has raised concerns about the efficacy of currently available therapies and poses a challenge to clinicians. Gemifloxacin is a synthetic fluoroquinolone antimicrobial agent exhibiting potent activity against most Gram negative and Gram positive organisms. Hence, this study was planned to evaluate the efficacy of gemifloxacin as an empirical therapy in pneumonia.
- Publication
Lung India : official organ of Indian Chest Society, 2012, Vol 29, Issue 3, p248
- ISSN
0974-598X
- Publication type
Journal Article
- DOI
10.4103/0970-2113.99109